about
Inactivation of p53 rescues the maintenance of high risk HPV DNA genomes deficient in expression of E6Association of the human papillomavirus type 11 E1 protein with histone H1Two classes of human papillomavirus type 16 E1 mutants suggest pleiotropic conformational constraints affecting E1 multimerization, E2 interaction, and interaction with cellular proteinsExpression of the papillomavirus E2 protein in HeLa cells leads to apoptosisBromodomain protein 4 mediates the papillomavirus E2 transcriptional activation functionIdentification of the structural and functional human homolog of the yeast ubiquitin conjugating enzyme UBC9Brd4-independent transcriptional repression function of the papillomavirus e2 proteinsA Small Molecule Inhibitor Selectively Induces Apoptosis in Cells Transformed by High Risk Human Papilloma VirusesThe papillomavirus E1 helicase activates a cellular DNA damage response in viral replication fociThe cellular DNA polymerase alpha-primase is required for papillomavirus DNA replication and associates with the viral E1 helicaseDNA replication of human papillomavirus type 31 is modulated by elements of the upstream regulatory region that lie 5' of the minimal originViral DNA Replication Orientation and hnRNPs Regulate Transcription of the Human Papillomavirus 18 Late Promoter.Variant upstream regulatory region sequences differentially regulate human papillomavirus type 16 DNA replication throughout the viral life cycle.Mechanisms of human papillomavirus E2-mediated repression of viral oncogene expression and cervical cancer cell growth inhibition.Differentiation-dependent chromatin rearrangement coincides with activation of human papillomavirus type 31 late gene expression.Brd2/RING3 interacts with a chromatin-binding domain in the Kaposi's Sarcoma-associated herpesvirus latency-associated nuclear antigen 1 (LANA-1) that is required for multiple functions of LANA-1.Construction of a full transcription map of human papillomavirus type 18 during productive viral infection.E1 empty set E4 protein of human papillomavirus type 16 associates with mitochondria.Mitotic chromosome-binding activity of latency-associated nuclear antigen 1 is required for DNA replication from terminal repeat sequence of Kaposi's sarcoma-associated herpesvirusGene- and protein-delivered zinc finger-staphylococcal nuclease hybrid for inhibition of DNA replication of human papillomavirus.Different modes of human papillomavirus DNA replication during maintenanceInhibition of DNA replication of human papillomavirus by artificial zinc finger proteins.Papillomavirus E2 induces senescence in HPV-positive cells via pRB- and p21(CIP)-dependent pathways.Control of HPV 18 DNA replication by cellular and viral transcription factors.Brd4 is displaced from HPV replication factories as they expand and amplify viral DNADevelopment of quantitative and high-throughput assays of polyomavirus and papillomavirus DNA replicationHuman papillomavirus type 31 oncoproteins E6 and E7 are required for the maintenance of episomes during the viral life cycle in normal human keratinocytes.The transcription map of HPV11 in U2OS cells adequately reflects the initial and stable replication phases of the viral genome.The bovine papillomavirus E2 protein modulates the assembly of but is not stably maintained in a replication-competent multimeric E1-replication origin complex.E1 protein of human papillomavirus type 1a is sufficient for initiation of viral DNA replication.The E1 protein of human papillomavirus type 16 is dispensable for maintenance replication of the viral genome.A switch region determines the cell type-specific positive or negative action of YY1 on the activity of the human papillomavirus type 18 promoter.Suppression of cellular proliferation by the papillomavirus E2 protein.Genetic analysis of the activation domain of bovine papillomavirus protein E2: its role in transcription and replication.Enhanced transcriptional activation by E2 proteins from the oncogenic human papillomavirusesFunctional interactions between papillomavirus E1 and E2 proteins.Evidence for a switch in the mode of human papillomavirus type 16 DNA replication during the viral life cycleDifferential effects of the splice acceptor at nucleotide 3295 of human papillomavirus type 31 on stable and transient viral replication.Recombinant Listeria monocytogenes vaccination eliminates papillomavirus-induced tumors and prevents papilloma formation from viral DNABinding of the human papillomavirus E1 origin-recognition protein is regulated through complex formation with the E2 enhancer-binding protein.
P2860
Q21558774-1B5D9CC8-3C15-4285-8E85-FBB9633BAAC9Q24316941-26A1DEB3-09C1-4A1C-9081-171B2B8D228AQ24317609-F9AF430C-A751-4CA0-A970-F1162F6B939BQ24532089-6EB00037-79A9-4A48-90AD-1C49C0FAE5FCQ24545850-054C0F44-0C2D-4DF9-B785-620B7ACE5B29Q24546896-CDCC4315-144C-40A4-AE3E-1DBCBF087F13Q24671845-37BEC331-3DD2-4B6F-B6A5-D28719670936Q28550190-121AF876-B1F3-455E-9A88-78DE036F9E2EQ28740852-B612B661-B6A6-4435-9BAC-BE2D35E58F4EQ30420704-6E988D2A-B293-4236-B3C5-43005F94EBF4Q33652772-53F90039-44D2-4974-9114-007494ACF539Q33741262-34D8C7EA-9B64-402A-9C3C-5657597C1E70Q33780601-90F72838-0626-41B1-9B9F-6B31213E8F33Q33802567-41021099-1ED7-4FBD-9CAD-50F0494589FEQ33847281-6CFD7A0D-136C-4F01-AE8C-0D17D1068867Q34092739-8FF9427A-8EFC-4D5D-859D-3EEA7309BBBDQ34193290-B3E4864B-F7F5-4A3B-BDD6-4EC9D9AFECC1Q34436669-4ACC020B-0B21-4342-98CB-511F096A4AACQ34437977-7661D0A6-460E-477C-AAF3-09CFF04FEA3BQ34599142-2F7B1515-ACD0-4F2B-82D3-D22B4449B9E3Q34647386-0892038F-5CE9-4E38-9804-BDF85E70ECF4Q34648251-DAC57C2D-92EB-40A7-8DEB-3F9AB4A14A7AQ34676199-8C615E75-3756-4BC9-810A-EDDBC7ACB2D5Q34782217-58689C65-C69E-404D-BED0-9F5CFBF5DD5EQ35053049-1DA5F08A-4182-4039-8720-9FF9231B8F97Q35158114-123DB618-E38A-4EE1-8925-B878D9D7FAACQ35550275-4C01DB07-288F-496E-9FB8-114068FE1B70Q35552912-4F05CF96-E9C4-4B07-8228-A49395E2C074Q35753237-B38EC120-2B73-4063-85D0-5EC1B7F2C673Q35800028-272D6AAB-F71D-473B-B55E-09AD328A9203Q35826243-782BDFC4-3601-4F6C-89A0-EE23831CE5E0Q35828407-42B82EAD-EB98-4E85-AE99-037047E7C13AQ35852233-79A0483C-610A-4801-970D-E2A9253C3561Q35863067-10FFB703-F1DF-4328-9508-807EAA625ABBQ35871772-CD3D133F-E3F5-4DE7-82E3-9A952AFC0253Q35883567-73862063-4BCF-4AD1-A54A-145AD6A472BCQ35894649-42B3FB3A-FA86-400D-96B1-7F7055A532ADQ35897893-1C539897-6377-489D-B10E-EF42D55496E0Q35898471-A1DBDA89-207D-4631-A29B-62BB534B8BA1Q35980936-DAC56F11-963E-415B-BAE1-0C1A8B5105CD
P2860
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Transient replication of human papillomavirus DNAs.
@ast
Transient replication of human papillomavirus DNAs.
@en
type
label
Transient replication of human papillomavirus DNAs.
@ast
Transient replication of human papillomavirus DNAs.
@en
prefLabel
Transient replication of human papillomavirus DNAs.
@ast
Transient replication of human papillomavirus DNAs.
@en
P2093
P2860
P1433
P1476
Transient replication of human papillomavirus DNAs.
@en
P2093
Del Vecchio AM
Romanczuk H
P2860
P304
P407
P577
1992-10-01T00:00:00Z